Share Price and Basic Stock Data
Last Updated: January 22, 2026, 5:48 pm
| PEG Ratio | -3.70 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Fairchem Organics Ltd operates in the organic chemicals sector, focusing on specialty chemicals. The company’s market capitalization stood at ₹871 Cr, with a current share price of ₹666. Over the past few quarters, Fairchem’s revenue has shown variability. The sales for the quarter ending September 2023 recorded ₹152.21 Cr, a slight decrease from ₹160.59 Cr in June 2023. Annual sales figures indicate a peak of ₹648 Cr in the financial year ending March 2023, followed by a decline to ₹621 Cr in March 2024, and a further projected drop to ₹538 Cr for March 2025. This downward trend in revenue raises concerns about the company’s growth trajectory, especially given the industry’s competitive landscape. The trailing twelve months (TTM) revenue stands at ₹477 Cr, reflecting the challenges the company faces in maintaining consistent sales amidst fluctuating market demands.
Profitability and Efficiency Metrics
Fairchem’s profitability metrics reveal a declining trend. The operating profit margin (OPM) stood at a modest 3.76% for the current financial year, significantly lower than the historical peak of 16% recorded in March 2020. The net profit for the quarter ending September 2023 was ₹10.29 Cr, down from ₹13.85 Cr in June 2024, showcasing the impact of rising operational costs. The interest coverage ratio (ICR) is robust at 12.03x, indicating that the company can comfortably meet its interest obligations. However, the return on equity (ROE) at 7.51% and return on capital employed (ROCE) at 10.2% are relatively low compared to industry standards, suggesting inefficient capital utilization. The company’s cash conversion cycle has expanded to 137 days, reflecting challenges in inventory management and receivables collection, which could further strain liquidity and profitability.
Balance Sheet Strength and Financial Ratios
Fairchem’s balance sheet presents a mixed picture. The company reported total assets of ₹402 Cr as of March 2025, with reserves amounting to ₹281 Cr and borrowings of ₹54 Cr. The low debt levels indicate a conservative capital structure, with a total debt to equity ratio of 0.20, suggesting limited financial risk. However, the company’s book value per share has risen to ₹231.96, which is a positive indicator of underlying asset strength. The price-to-book value ratio stands at 3.78x, implying that the stock may be overvalued relative to its net assets. Furthermore, the current ratio is at 2.30, reflecting solid liquidity. Despite these strengths, the declining trend in net profit and operating profit raises concerns about cash flow sustainability, which is critical for future growth and operational flexibility.
Shareholding Pattern and Investor Confidence
Fairchem’s shareholding structure reveals a strong promoter presence, with promoters holding 61.20% of the shares as of March 2025, indicating substantial insider confidence in the company. Foreign institutional investors (FIIs) account for 6.18% and domestic institutional investors (DIIs) hold 5.77%, showcasing some level of institutional backing. However, the public shareholding has decreased to 26.86%, reflecting potential concerns among retail investors. The total number of shareholders has also declined to 28,990, which may suggest waning interest in the stock among the broader investing community. The declining public participation could affect the stock’s liquidity and market perception, which are crucial for maintaining investor confidence in the long term.
Outlook, Risks, and Final Insight
The outlook for Fairchem Organics Ltd appears challenging, given the recent decline in revenue and profitability metrics. Key risks include rising operational costs, potential inefficiencies in inventory management, and a shrinking public shareholder base. These factors could hinder the company’s ability to capitalize on market opportunities. Conversely, strengths such as a solid balance sheet with low debt levels and a significant promoter stake could provide some stability. The company must focus on improving operational efficiencies and enhancing profit margins to attract investor confidence and improve market performance. If Fairchem can successfully address its operational challenges and stabilize its revenue streams, it could position itself for recovery and growth in the coming years. However, failure to do so may lead to further declines in financial performance and investor sentiment.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujchem Distillers India Ltd | 51.9 Cr. | 145 | 456/135 | 121 | 392 | 0.07 % | 0.21 % | 0.09 % | 1.00 |
| Elantas Beck India Ltd | 7,005 Cr. | 8,836 | 14,250/8,150 | 50.7 | 1,177 | 0.08 % | 23.0 % | 17.4 % | 10.0 |
| Crestchem Ltd | 28.0 Cr. | 93.4 | 329/84.1 | 13.9 | 26.9 | 1.07 % | 59.9 % | 44.1 % | 10.0 |
| Chemiesynth (Vapi) Ltd | 11.6 Cr. | 37.6 | 37.6/35.8 | 32.8 | 0.00 % | 3.10 % | 0.99 % | 10.0 | |
| ARCL Organics Ltd | 201 Cr. | 251 | 435/163 | 11.1 | 108 | 0.00 % | 20.4 % | 16.8 % | 10.0 |
| Industry Average | 4,436.00 Cr | 1,428.50 | 54.77 | 334.84 | 0.44% | 14.71% | 10.69% | 7.56 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 168.54 | 102.48 | 151.90 | 160.59 | 152.21 | 148.11 | 160.56 | 164.93 | 138.62 | 113.57 | 120.78 | 131.06 | 111.52 |
| Expenses | 159.22 | 98.81 | 132.66 | 148.96 | 135.38 | 128.36 | 141.79 | 143.16 | 129.86 | 105.74 | 116.36 | 125.83 | 107.33 |
| Operating Profit | 9.32 | 3.67 | 19.24 | 11.63 | 16.83 | 19.75 | 18.77 | 21.77 | 8.76 | 7.83 | 4.42 | 5.23 | 4.19 |
| OPM % | 5.53% | 3.58% | 12.67% | 7.24% | 11.06% | 13.33% | 11.69% | 13.20% | 6.32% | 6.89% | 3.66% | 3.99% | 3.76% |
| Other Income | 0.00 | 0.27 | 0.17 | 0.15 | 0.46 | 0.25 | 0.28 | 0.24 | 0.38 | 0.48 | 0.24 | 0.13 | 0.37 |
| Interest | 1.62 | 0.92 | 1.32 | 1.35 | 1.30 | 0.97 | 0.62 | 0.81 | 1.02 | 0.93 | 0.91 | 1.01 | 0.61 |
| Depreciation | 2.05 | 2.09 | 2.13 | 2.15 | 2.18 | 2.40 | 2.55 | 2.59 | 2.64 | 2.67 | 2.64 | 2.74 | 2.78 |
| Profit before tax | 5.65 | 0.93 | 15.96 | 8.28 | 13.81 | 16.63 | 15.88 | 18.61 | 5.48 | 4.71 | 1.11 | 1.61 | 1.17 |
| Tax % | 29.20% | 35.48% | 25.69% | 25.97% | 25.56% | 25.86% | 25.88% | 25.63% | 26.82% | 25.48% | 46.85% | 27.33% | 35.04% |
| Net Profit | 4.00 | 0.61 | 11.86 | 6.12 | 10.29 | 12.33 | 11.76 | 13.85 | 4.01 | 3.52 | 0.59 | 1.17 | 0.77 |
| EPS in Rs | 3.07 | 0.47 | 9.11 | 4.70 | 7.90 | 9.47 | 9.03 | 10.64 | 3.08 | 2.70 | 0.45 | 0.90 | 0.59 |
Last Updated: January 1, 2026, 7:37 pm
Below is a detailed analysis of the quarterly data for Fairchem Organics Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 111.52 Cr.. The value appears to be declining and may need further review. It has decreased from 131.06 Cr. (Jun 2025) to 111.52 Cr., marking a decrease of 19.54 Cr..
- For Expenses, as of Sep 2025, the value is 107.33 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 125.83 Cr. (Jun 2025) to 107.33 Cr., marking a decrease of 18.50 Cr..
- For Operating Profit, as of Sep 2025, the value is 4.19 Cr.. The value appears to be declining and may need further review. It has decreased from 5.23 Cr. (Jun 2025) to 4.19 Cr., marking a decrease of 1.04 Cr..
- For OPM %, as of Sep 2025, the value is 3.76%. The value appears to be declining and may need further review. It has decreased from 3.99% (Jun 2025) to 3.76%, marking a decrease of 0.23%.
- For Other Income, as of Sep 2025, the value is 0.37 Cr.. The value appears strong and on an upward trend. It has increased from 0.13 Cr. (Jun 2025) to 0.37 Cr., marking an increase of 0.24 Cr..
- For Interest, as of Sep 2025, the value is 0.61 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.01 Cr. (Jun 2025) to 0.61 Cr., marking a decrease of 0.40 Cr..
- For Depreciation, as of Sep 2025, the value is 2.78 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.74 Cr. (Jun 2025) to 2.78 Cr., marking an increase of 0.04 Cr..
- For Profit before tax, as of Sep 2025, the value is 1.17 Cr.. The value appears to be declining and may need further review. It has decreased from 1.61 Cr. (Jun 2025) to 1.17 Cr., marking a decrease of 0.44 Cr..
- For Tax %, as of Sep 2025, the value is 35.04%. The value appears to be increasing, which may not be favorable. It has increased from 27.33% (Jun 2025) to 35.04%, marking an increase of 7.71%.
- For Net Profit, as of Sep 2025, the value is 0.77 Cr.. The value appears to be declining and may need further review. It has decreased from 1.17 Cr. (Jun 2025) to 0.77 Cr., marking a decrease of 0.40 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.59. The value appears to be declining and may need further review. It has decreased from 0.90 (Jun 2025) to 0.59, marking a decrease of 0.31.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:23 am
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 306 | 397 | 643 | 648 | 621 | 538 | 477 |
| Expenses | 258 | 328 | 538 | 576 | 554 | 495 | 455 |
| Operating Profit | 49 | 69 | 105 | 72 | 67 | 43 | 22 |
| OPM % | 16% | 17% | 16% | 11% | 11% | 8% | 5% |
| Other Income | 6 | 0 | 0 | 1 | 1 | 1 | 1 |
| Interest | 7 | 7 | 7 | 6 | 4 | 4 | 3 |
| Depreciation | 6 | 7 | 7 | 8 | 9 | 11 | 11 |
| Profit before tax | 42 | 56 | 91 | 59 | 55 | 30 | 9 |
| Tax % | 18% | 24% | 26% | 26% | 26% | 27% | |
| Net Profit | 35 | 42 | 68 | 44 | 40 | 22 | 6 |
| EPS in Rs | 32.62 | 52.15 | 33.41 | 31.10 | 16.87 | 4.64 | |
| Dividend Payout % | 0% | 11% | 25% | 22% | 24% | 44% |
YoY Net Profit Growth
| Year | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 20.00% | 61.90% | -35.29% | -9.09% | -45.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | 41.90% | -97.20% | 26.20% | -35.91% |
Fairchem Organics Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 5 years from 2020-2021 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 12% |
| 3 Years: | -6% |
| TTM: | -19% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -9% |
| 3 Years: | -31% |
| TTM: | -81% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -26% |
| 1 Year: | -38% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 19% |
| 3 Years: | 13% |
| Last Year: | 8% |
Last Updated: September 5, 2025, 3:50 am
Balance Sheet
Last Updated: December 4, 2025, 1:13 am
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.00 | 13 | 13 | 13 | 13 | 13 | 13 |
| Reserves | 127 | 156 | 219 | 246 | 277 | 289 | 281 |
| Borrowings | 67 | 57 | 62 | 50 | 7 | 63 | 54 |
| Other Liabilities | 25 | 33 | 30 | 33 | 37 | 37 | 40 |
| Total Liabilities | 219 | 259 | 324 | 342 | 334 | 402 | 388 |
| Fixed Assets | 126 | 126 | 141 | 156 | 191 | 201 | 199 |
| CWIP | 9 | 29 | 42 | 35 | 6 | 12 | 14 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 83 | 103 | 141 | 151 | 137 | 189 | 175 |
| Total Assets | 219 | 259 | 324 | 342 | 334 | 402 | 388 |
Below is a detailed analysis of the balance sheet data for Fairchem Organics Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 13.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 13.00 Cr..
- For Reserves, as of Sep 2025, the value is 281.00 Cr.. The value appears to be declining and may need further review. It has decreased from 289.00 Cr. (Mar 2025) to 281.00 Cr., marking a decrease of 8.00 Cr..
- For Borrowings, as of Sep 2025, the value is 54.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 63.00 Cr. (Mar 2025) to 54.00 Cr., marking a decrease of 9.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 40.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 37.00 Cr. (Mar 2025) to 40.00 Cr., marking an increase of 3.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 388.00 Cr.. The value appears to be improving (decreasing). It has decreased from 402.00 Cr. (Mar 2025) to 388.00 Cr., marking a decrease of 14.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 199.00 Cr.. The value appears to be declining and may need further review. It has decreased from 201.00 Cr. (Mar 2025) to 199.00 Cr., marking a decrease of 2.00 Cr..
- For CWIP, as of Sep 2025, the value is 14.00 Cr.. The value appears strong and on an upward trend. It has increased from 12.00 Cr. (Mar 2025) to 14.00 Cr., marking an increase of 2.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 175.00 Cr.. The value appears to be declining and may need further review. It has decreased from 189.00 Cr. (Mar 2025) to 175.00 Cr., marking a decrease of 14.00 Cr..
- For Total Assets, as of Sep 2025, the value is 388.00 Cr.. The value appears to be declining and may need further review. It has decreased from 402.00 Cr. (Mar 2025) to 388.00 Cr., marking a decrease of 14.00 Cr..
Notably, the Reserves (281.00 Cr.) exceed the Borrowings (54.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Free Cash Flow | -18.00 | 12.00 | 43.00 | 22.00 | 60.00 | -20.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Debtor Days | 45 | 43 | 35 | 35 | 33 | 58 |
| Inventory Days | 65 | 64 | 57 | 61 | 57 | 87 |
| Days Payable | 12 | 15 | 7 | 8 | 11 | 8 |
| Cash Conversion Cycle | 98 | 91 | 85 | 89 | 80 | 137 |
| Working Capital Days | 14 | 43 | 40 | 46 | 63 | 68 |
| ROCE % | 30% | 38% | 22% | 19% | 10% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 16.88 | 31.10 | 33.41 | 52.15 | 32.63 |
| Diluted EPS (Rs.) | 16.88 | 31.10 | 33.41 | 52.15 | 32.63 |
| Cash EPS (Rs.) | 24.97 | 38.23 | 39.67 | 57.63 | 37.68 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 231.96 | 222.67 | 199.11 | 178.29 | 129.59 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 231.96 | 222.67 | 199.11 | 178.29 | 129.59 |
| Dividend / Share (Rs.) | 7.50 | 7.50 | 7.50 | 13.00 | 3.50 |
| Revenue From Operations / Share (Rs.) | 413.10 | 477.29 | 497.69 | 493.96 | 304.56 |
| PBDIT / Share (Rs.) | 33.88 | 52.31 | 56.07 | 80.81 | 52.96 |
| PBIT / Share (Rs.) | 25.79 | 45.19 | 49.81 | 75.34 | 47.91 |
| PBT / Share (Rs.) | 22.98 | 41.93 | 45.00 | 70.07 | 42.67 |
| Net Profit / Share (Rs.) | 16.88 | 31.10 | 33.41 | 52.15 | 32.63 |
| PBDIT Margin (%) | 8.20 | 10.96 | 11.26 | 16.36 | 17.38 |
| PBIT Margin (%) | 6.24 | 9.46 | 10.00 | 15.25 | 15.73 |
| PBT Margin (%) | 5.56 | 8.78 | 9.04 | 14.18 | 14.01 |
| Net Profit Margin (%) | 4.08 | 6.51 | 6.71 | 10.55 | 10.71 |
| Return on Networth / Equity (%) | 7.27 | 13.96 | 16.77 | 29.25 | 25.17 |
| Return on Capital Employeed (%) | 10.38 | 19.08 | 23.52 | 38.21 | 30.01 |
| Return On Assets (%) | 5.46 | 12.11 | 12.70 | 20.95 | 16.42 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.04 | 0.15 |
| Total Debt / Equity (X) | 0.20 | 0.02 | 0.19 | 0.26 | 0.28 |
| Asset Turnover Ratio (%) | 1.46 | 1.84 | 1.94 | 2.21 | 1.66 |
| Current Ratio (X) | 2.30 | 5.10 | 2.22 | 2.04 | 1.93 |
| Quick Ratio (X) | 1.17 | 2.42 | 1.03 | 0.99 | 1.04 |
| Inventory Turnover Ratio (X) | 6.81 | 8.31 | 6.69 | 8.17 | 6.89 |
| Dividend Payout Ratio (NP) (%) | 44.44 | 24.11 | 38.91 | 6.71 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 30.04 | 19.61 | 32.77 | 6.07 | 0.00 |
| Earning Retention Ratio (%) | 55.56 | 75.89 | 61.09 | 93.29 | 0.00 |
| Cash Earning Retention Ratio (%) | 69.96 | 80.39 | 67.23 | 93.93 | 0.00 |
| Interest Coverage Ratio (X) | 12.03 | 16.07 | 11.66 | 15.35 | 10.11 |
| Interest Coverage Ratio (Post Tax) (X) | 6.99 | 10.55 | 7.95 | 10.91 | 7.23 |
| Enterprise Value (Cr.) | 1202.96 | 1552.81 | 1240.34 | 2021.19 | 1022.58 |
| EV / Net Operating Revenue (X) | 2.24 | 2.50 | 1.91 | 3.14 | 2.58 |
| EV / EBITDA (X) | 27.27 | 22.80 | 16.99 | 19.21 | 14.83 |
| MarketCap / Net Operating Revenue (X) | 2.12 | 2.49 | 1.84 | 3.05 | 2.46 |
| Retention Ratios (%) | 55.55 | 75.88 | 61.08 | 93.28 | 0.00 |
| Price / BV (X) | 3.78 | 5.33 | 4.59 | 8.44 | 5.78 |
| Price / Net Operating Revenue (X) | 2.12 | 2.49 | 1.84 | 3.05 | 2.46 |
| EarningsYield | 0.01 | 0.02 | 0.03 | 0.03 | 0.04 |
After reviewing the key financial ratios for Fairchem Organics Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 16.88. This value is within the healthy range. It has decreased from 31.10 (Mar 24) to 16.88, marking a decrease of 14.22.
- For Diluted EPS (Rs.), as of Mar 25, the value is 16.88. This value is within the healthy range. It has decreased from 31.10 (Mar 24) to 16.88, marking a decrease of 14.22.
- For Cash EPS (Rs.), as of Mar 25, the value is 24.97. This value is within the healthy range. It has decreased from 38.23 (Mar 24) to 24.97, marking a decrease of 13.26.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 231.96. It has increased from 222.67 (Mar 24) to 231.96, marking an increase of 9.29.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 231.96. It has increased from 222.67 (Mar 24) to 231.96, marking an increase of 9.29.
- For Dividend / Share (Rs.), as of Mar 25, the value is 7.50. This value exceeds the healthy maximum of 3. There is no change compared to the previous period (Mar 24) which recorded 7.50.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 413.10. It has decreased from 477.29 (Mar 24) to 413.10, marking a decrease of 64.19.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 33.88. This value is within the healthy range. It has decreased from 52.31 (Mar 24) to 33.88, marking a decrease of 18.43.
- For PBIT / Share (Rs.), as of Mar 25, the value is 25.79. This value is within the healthy range. It has decreased from 45.19 (Mar 24) to 25.79, marking a decrease of 19.40.
- For PBT / Share (Rs.), as of Mar 25, the value is 22.98. This value is within the healthy range. It has decreased from 41.93 (Mar 24) to 22.98, marking a decrease of 18.95.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 16.88. This value is within the healthy range. It has decreased from 31.10 (Mar 24) to 16.88, marking a decrease of 14.22.
- For PBDIT Margin (%), as of Mar 25, the value is 8.20. This value is below the healthy minimum of 10. It has decreased from 10.96 (Mar 24) to 8.20, marking a decrease of 2.76.
- For PBIT Margin (%), as of Mar 25, the value is 6.24. This value is below the healthy minimum of 10. It has decreased from 9.46 (Mar 24) to 6.24, marking a decrease of 3.22.
- For PBT Margin (%), as of Mar 25, the value is 5.56. This value is below the healthy minimum of 10. It has decreased from 8.78 (Mar 24) to 5.56, marking a decrease of 3.22.
- For Net Profit Margin (%), as of Mar 25, the value is 4.08. This value is below the healthy minimum of 5. It has decreased from 6.51 (Mar 24) to 4.08, marking a decrease of 2.43.
- For Return on Networth / Equity (%), as of Mar 25, the value is 7.27. This value is below the healthy minimum of 15. It has decreased from 13.96 (Mar 24) to 7.27, marking a decrease of 6.69.
- For Return on Capital Employeed (%), as of Mar 25, the value is 10.38. This value is within the healthy range. It has decreased from 19.08 (Mar 24) to 10.38, marking a decrease of 8.70.
- For Return On Assets (%), as of Mar 25, the value is 5.46. This value is within the healthy range. It has decreased from 12.11 (Mar 24) to 5.46, marking a decrease of 6.65.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.20. This value is within the healthy range. It has increased from 0.02 (Mar 24) to 0.20, marking an increase of 0.18.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.46. It has decreased from 1.84 (Mar 24) to 1.46, marking a decrease of 0.38.
- For Current Ratio (X), as of Mar 25, the value is 2.30. This value is within the healthy range. It has decreased from 5.10 (Mar 24) to 2.30, marking a decrease of 2.80.
- For Quick Ratio (X), as of Mar 25, the value is 1.17. This value is within the healthy range. It has decreased from 2.42 (Mar 24) to 1.17, marking a decrease of 1.25.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.81. This value is within the healthy range. It has decreased from 8.31 (Mar 24) to 6.81, marking a decrease of 1.50.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 44.44. This value is within the healthy range. It has increased from 24.11 (Mar 24) to 44.44, marking an increase of 20.33.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 30.04. This value is within the healthy range. It has increased from 19.61 (Mar 24) to 30.04, marking an increase of 10.43.
- For Earning Retention Ratio (%), as of Mar 25, the value is 55.56. This value is within the healthy range. It has decreased from 75.89 (Mar 24) to 55.56, marking a decrease of 20.33.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 69.96. This value is within the healthy range. It has decreased from 80.39 (Mar 24) to 69.96, marking a decrease of 10.43.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 12.03. This value is within the healthy range. It has decreased from 16.07 (Mar 24) to 12.03, marking a decrease of 4.04.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 6.99. This value is within the healthy range. It has decreased from 10.55 (Mar 24) to 6.99, marking a decrease of 3.56.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,202.96. It has decreased from 1,552.81 (Mar 24) to 1,202.96, marking a decrease of 349.85.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.24. This value is within the healthy range. It has decreased from 2.50 (Mar 24) to 2.24, marking a decrease of 0.26.
- For EV / EBITDA (X), as of Mar 25, the value is 27.27. This value exceeds the healthy maximum of 15. It has increased from 22.80 (Mar 24) to 27.27, marking an increase of 4.47.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.12. This value is within the healthy range. It has decreased from 2.49 (Mar 24) to 2.12, marking a decrease of 0.37.
- For Retention Ratios (%), as of Mar 25, the value is 55.55. This value is within the healthy range. It has decreased from 75.88 (Mar 24) to 55.55, marking a decrease of 20.33.
- For Price / BV (X), as of Mar 25, the value is 3.78. This value exceeds the healthy maximum of 3. It has decreased from 5.33 (Mar 24) to 3.78, marking a decrease of 1.55.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.12. This value is within the healthy range. It has decreased from 2.49 (Mar 24) to 2.12, marking a decrease of 0.37.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.02 (Mar 24) to 0.01, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Fairchem Organics Ltd:
- Net Profit Margin: 4.08%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 10.38% (Industry Average ROCE: 14.71%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 7.27% (Industry Average ROE: 10.69%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 6.99
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.17
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 142 (Industry average Stock P/E: 54.77)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.2
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 4.08%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Organic - Others | 253/P & 312, Village Chekhala, Ahmedabad District Gujarat 382115 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Nahoosh Jariwala | Chairman & Managing Director |
| Mr. Sudhin Choksey | Independent Director |
| Mr. Venkatraman Srinivasan | Independent Director |
| Mr. Darius Pandole | Independent Director |
| Ms. Sonal Ambani | Independent Director |
| Mr. Sumit Maheshwari | Nominee Director |
FAQ
What is the intrinsic value of Fairchem Organics Ltd?
Fairchem Organics Ltd's intrinsic value (as of 22 January 2026) is ₹1202.00 which is 82.40% higher the current market price of ₹659.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹859 Cr. market cap, FY2025-2026 high/low of ₹1,230/542, reserves of ₹281 Cr, and liabilities of ₹388 Cr.
What is the Market Cap of Fairchem Organics Ltd?
The Market Cap of Fairchem Organics Ltd is 859 Cr..
What is the current Stock Price of Fairchem Organics Ltd as on 22 January 2026?
The current stock price of Fairchem Organics Ltd as on 22 January 2026 is ₹659.
What is the High / Low of Fairchem Organics Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Fairchem Organics Ltd stocks is ₹1,230/542.
What is the Stock P/E of Fairchem Organics Ltd?
The Stock P/E of Fairchem Organics Ltd is 142.
What is the Book Value of Fairchem Organics Ltd?
The Book Value of Fairchem Organics Ltd is 226.
What is the Dividend Yield of Fairchem Organics Ltd?
The Dividend Yield of Fairchem Organics Ltd is 1.14 %.
What is the ROCE of Fairchem Organics Ltd?
The ROCE of Fairchem Organics Ltd is 10.2 %.
What is the ROE of Fairchem Organics Ltd?
The ROE of Fairchem Organics Ltd is 7.51 %.
What is the Face Value of Fairchem Organics Ltd?
The Face Value of Fairchem Organics Ltd is 10.0.